Source: Investing.com ↗

Sagimet Biosciences director George Kemble sells $201,146 in shares

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

BTC/USDT

$77,110.00

+1.24%

ETH/USDT

$2,449.23

+3.05%

USDC/USDT

$0.9999

-0.01%

XRP/USDT

$1.48

+1.37%

SOL/USDT

$94.19

+1.64%